logo

Beam Therapeutics Inc: Analyzing BEAM Stock Trends

HCCC Stock

In terms of market performance, Beam Therapeutics Inc had a fairly uneven. The highest value for the stock in the past year was $49.50 on 02/27/24, and the lowest value was recorded at $20.84 on 04/25/24.

52-week price history of BEAM Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Beam Therapeutics Inc’s current trading price is -42.28% away from its 52-week high, while its distance from the 52-week low is 37.09%. The stock’s price range during the 52-week period has remained between $20.84 and $49.50. In the Healthcare sector, the company’s shares saw a trading volume of around 1.13 million for the day, which was evidently lower than the average daily volume of 1.13 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Beam Therapeutics Inc (BEAM) has experienced a quarterly rise of 5.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.37B and boasts a workforce of 436 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 25.59, with a change in price of +3.06. Similarly, Beam Therapeutics Inc recorded 1,099,927 in trading volume during the last 100 days, posting a change of +12.00%.

Examining BEAM’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for BEAM stands at 0.20. Similarly, the long-term debt-to-equity ratio is also 0.19.

BEAM Stock Stochastic Average

Beam Therapeutics Inc’s raw stochastic average for the past 50 days is presently 71.41%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 94.11%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 74.88% and 72.27%, respectively.

BEAM Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant gain of 15.20% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 19.14%. Over the past 30 days, the price of BEAM has fallen by 11.86%. And in the last five days, it has surged by 2.70%.

Most Popular